Less than 1 min 06/05/21
Author name: John Ross

Linking the “D” & “M” in CDMO

In this article with ONdrugDelivery, John Ross, President of Metrics Contract Services and Mayne Pharma US, explains the benefits of adding the “D” to “CMO” to capture the integrated offering of development through to commercialization CDMOs are able to offer. “DErug manufacturers increasingly turn to integrated contract development and manufacturing organisations (CDMOs) with advanced process development and scale-up technologies to realise measurable efficiencies and cost savings without compromising patient safety and product quality.” Read the full article here.

Related Content